H. Lundbeck A/S
Notice of annual general meeting
DGAP-News: H. Lundbeck A/S 2015-02-24 / 10:51 --------------------------------------------------------------------- Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Wednesday 25 March 2015 at 10.00 am The general meeting will be held at the offices of the Company at: H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby Lundbeck contacts Investors: Media: Palle Holm Olesen Mads Kronborg Vice President, Investor Relations Director, Media Relations PALO@lundbeck.com MAVK@lundbeck.com +45 36 43 24 26 +45 36 43 30 00 About Lundbeck H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 50 years, we have been at the forefront of research within neuroscience. Our key areas of focus are alcohol dependence, Alzheimer's disease, bipolar disorder, depression/anxiety, epilepsy, Huntington's disease, Parkinson's disease, schizophrenia, stroke and symptomatic neurogenic orthostatic hypotension (NOH). An estimated 700 million people worldwide are living with brain disease and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain disease - we call this Progress in Mind. Read more at www.lundbeck.com/global/about-us/progress-in-mind. Our approximately 6,000 employees in 57 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programs and our products are available in more 100 countries. We have research centers in China, Denmark and the United States and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of approximately DKK 13.5 billion in 2014 (EUR 1.8 billion; USD 2.4 billion). For additional information, we encourage you to visit our corporate site www.lundbeck.com. News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-02-24 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: H. Lundbeck A/S Denmark ISIN: DK0010287234 End of News DGAP News-Service --------------------------------------------------------------------- 326323 2015-02-24
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden